Identification and characterization of inhibitors of West Nile virus

Francesc Puig-Basagoiti, Min Qing, Hongping Dong, Bo Zhang, Gang Zou, Zhiming Yuan, Pei-Yong Shi

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Although flaviviruses cause significant human diseases, no antiviral therapy is currently available for clinical treatment of these pathogens. To identify flavivirus inhibitors, we performed a high-throughput screening of compound libraries using cells containing luciferase-reporting replicon of West Nile viruses (WNV). Five novel small molecular inhibitors of WNV were identified from libraries containing 96,958 compounds. The inhibitors suppress epidemic strain of WNV in cell culture, with EC 50 (50% effective concentration) values of 10. Viral titer reduction assays, using various flaviviruses and nonflaviviruses, showed that the compounds have distinct antiviral spectra. Mode-of-action analysis showed that the inhibitors block distinct steps of WNV replication: four compounds inhibit viral RNA syntheses, while the other compound suppresses both viral translation and RNA syntheses. Biochemical enzyme assays showed that two compounds selectively inhibit viral RNA-dependent RNA polymerase (RdRp), while another compound specifically inhibits both RdRp and methyltransferase. The identified compounds could potentially be developed for treatment of flavivirus infections.

Original languageEnglish (US)
Pages (from-to)71-79
Number of pages9
JournalAntiviral Research
Volume83
Issue number1
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

West Nile virus
Flavivirus
Viral RNA
RNA Replicase
Libraries
Antiviral Agents
Flavivirus Infections
Replicon
Methyltransferases
Enzyme Assays
Virus Replication
Luciferases
Cell Culture Techniques
Therapeutics

Keywords

  • Antiviral drug discovery
  • Flavivirus replication
  • High-throughput screening
  • RNA cap methyltransferase
  • RNA-dependent RNA polymerase
  • West Nile virus

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Identification and characterization of inhibitors of West Nile virus. / Puig-Basagoiti, Francesc; Qing, Min; Dong, Hongping; Zhang, Bo; Zou, Gang; Yuan, Zhiming; Shi, Pei-Yong.

In: Antiviral Research, Vol. 83, No. 1, 07.2009, p. 71-79.

Research output: Contribution to journalArticle

Puig-Basagoiti, F, Qing, M, Dong, H, Zhang, B, Zou, G, Yuan, Z & Shi, P-Y 2009, 'Identification and characterization of inhibitors of West Nile virus', Antiviral Research, vol. 83, no. 1, pp. 71-79. https://doi.org/10.1016/j.antiviral.2009.03.005
Puig-Basagoiti F, Qing M, Dong H, Zhang B, Zou G, Yuan Z et al. Identification and characterization of inhibitors of West Nile virus. Antiviral Research. 2009 Jul;83(1):71-79. https://doi.org/10.1016/j.antiviral.2009.03.005
Puig-Basagoiti, Francesc ; Qing, Min ; Dong, Hongping ; Zhang, Bo ; Zou, Gang ; Yuan, Zhiming ; Shi, Pei-Yong. / Identification and characterization of inhibitors of West Nile virus. In: Antiviral Research. 2009 ; Vol. 83, No. 1. pp. 71-79.
@article{dd94eb640f9a4446854469ddf2a76bee,
title = "Identification and characterization of inhibitors of West Nile virus",
abstract = "Although flaviviruses cause significant human diseases, no antiviral therapy is currently available for clinical treatment of these pathogens. To identify flavivirus inhibitors, we performed a high-throughput screening of compound libraries using cells containing luciferase-reporting replicon of West Nile viruses (WNV). Five novel small molecular inhibitors of WNV were identified from libraries containing 96,958 compounds. The inhibitors suppress epidemic strain of WNV in cell culture, with EC 50 (50{\%} effective concentration) values of 10. Viral titer reduction assays, using various flaviviruses and nonflaviviruses, showed that the compounds have distinct antiviral spectra. Mode-of-action analysis showed that the inhibitors block distinct steps of WNV replication: four compounds inhibit viral RNA syntheses, while the other compound suppresses both viral translation and RNA syntheses. Biochemical enzyme assays showed that two compounds selectively inhibit viral RNA-dependent RNA polymerase (RdRp), while another compound specifically inhibits both RdRp and methyltransferase. The identified compounds could potentially be developed for treatment of flavivirus infections.",
keywords = "Antiviral drug discovery, Flavivirus replication, High-throughput screening, RNA cap methyltransferase, RNA-dependent RNA polymerase, West Nile virus",
author = "Francesc Puig-Basagoiti and Min Qing and Hongping Dong and Bo Zhang and Gang Zou and Zhiming Yuan and Pei-Yong Shi",
year = "2009",
month = "7",
doi = "10.1016/j.antiviral.2009.03.005",
language = "English (US)",
volume = "83",
pages = "71--79",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Identification and characterization of inhibitors of West Nile virus

AU - Puig-Basagoiti, Francesc

AU - Qing, Min

AU - Dong, Hongping

AU - Zhang, Bo

AU - Zou, Gang

AU - Yuan, Zhiming

AU - Shi, Pei-Yong

PY - 2009/7

Y1 - 2009/7

N2 - Although flaviviruses cause significant human diseases, no antiviral therapy is currently available for clinical treatment of these pathogens. To identify flavivirus inhibitors, we performed a high-throughput screening of compound libraries using cells containing luciferase-reporting replicon of West Nile viruses (WNV). Five novel small molecular inhibitors of WNV were identified from libraries containing 96,958 compounds. The inhibitors suppress epidemic strain of WNV in cell culture, with EC 50 (50% effective concentration) values of 10. Viral titer reduction assays, using various flaviviruses and nonflaviviruses, showed that the compounds have distinct antiviral spectra. Mode-of-action analysis showed that the inhibitors block distinct steps of WNV replication: four compounds inhibit viral RNA syntheses, while the other compound suppresses both viral translation and RNA syntheses. Biochemical enzyme assays showed that two compounds selectively inhibit viral RNA-dependent RNA polymerase (RdRp), while another compound specifically inhibits both RdRp and methyltransferase. The identified compounds could potentially be developed for treatment of flavivirus infections.

AB - Although flaviviruses cause significant human diseases, no antiviral therapy is currently available for clinical treatment of these pathogens. To identify flavivirus inhibitors, we performed a high-throughput screening of compound libraries using cells containing luciferase-reporting replicon of West Nile viruses (WNV). Five novel small molecular inhibitors of WNV were identified from libraries containing 96,958 compounds. The inhibitors suppress epidemic strain of WNV in cell culture, with EC 50 (50% effective concentration) values of 10. Viral titer reduction assays, using various flaviviruses and nonflaviviruses, showed that the compounds have distinct antiviral spectra. Mode-of-action analysis showed that the inhibitors block distinct steps of WNV replication: four compounds inhibit viral RNA syntheses, while the other compound suppresses both viral translation and RNA syntheses. Biochemical enzyme assays showed that two compounds selectively inhibit viral RNA-dependent RNA polymerase (RdRp), while another compound specifically inhibits both RdRp and methyltransferase. The identified compounds could potentially be developed for treatment of flavivirus infections.

KW - Antiviral drug discovery

KW - Flavivirus replication

KW - High-throughput screening

KW - RNA cap methyltransferase

KW - RNA-dependent RNA polymerase

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=67349221783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349221783&partnerID=8YFLogxK

U2 - 10.1016/j.antiviral.2009.03.005

DO - 10.1016/j.antiviral.2009.03.005

M3 - Article

C2 - 19501258

AN - SCOPUS:67349221783

VL - 83

SP - 71

EP - 79

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 1

ER -